{"id":2551,"date":"2021-01-26T22:36:23","date_gmt":"2021-01-26T22:36:23","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2551"},"modified":"2023-08-29T18:01:53","modified_gmt":"2023-08-29T18:01:53","slug":"medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2551","title":{"rendered":"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b"},"content":{"rendered":"<p>\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=MDC&amp;lang=cn\">Medlab Clinical (ASX: MDC)<\/a>\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684\u76ee\u6807\u662f\u4e3a\u5df2\u786e\u8bca\u7684\u6162\u6027\u75be\u75c5(\u5305\u62ec\u75bc\u75db\u3001\u6291\u90c1\u75c7)\u5f00\u53d1\u6cbb\u7597\u9014\u5f84\u3002\u5176\u6700\u5148\u8fdb\u7684\u5019\u9009\u836f\u7269NanaBis&#x2122;\u662f\u4e00\u79cd\u57fa\u4e8e\u5927\u9ebb\u7d20\u7684\u836f\u7269\uff0c\u65e8\u5728\u6cbb\u7597\u764c\u75c7\u5f15\u8d77\u7684\u9aa8\u75db\u3002<\/p>\n<p>\u8be5\u836f\u7269\u5df2\u88ab\u6279\u51c6\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u82f1\u56fd\u8fdb\u884c\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0a\u5468Medlab\u5ba3\u5e03\u4e86\u8fd9\u4e00\u6d88\u606f<\/p>\n<p>Medlab\u8463\u4e8b\u603b\u7ecf\u7406Sean Hall\u535a\u58eb\u5728\u63a5\u53d7Small Caps\u91c7\u8bbf\u65f6\u8868\u793a\uff0c\u4ed6\u76f8\u4fe1\u516c\u53f8\u80fd\u591f\u8bc1\u660eNanaBis&#x2122;\u662f\u4e00\u79cd\u73b0\u5b9e\u4e16\u754c\u4e2d\u53ef\u884c\u7684\u9547\u75db\u7c7b\u963f\u7247\u7c7b\u836f\u7269\u66ff\u4ee3\u54c1\u3002<\/p>\n<p>\u4ed6\u8bf4\uff0cMedlab\u7684\u76ee\u6807\u662f\u901a\u8fc7\u4e09\u671f\u8bd5\u9a8c\uff0c\u201c\u826f\u597d\u7684\u5408\u4f5c\u4f19\u4f34\u548c\u975e\u5e38\u540c\u8d28\u578b\u7684\u60a3\u8005\u7ec4\uff0c\u5f97\u51fa\u4e00\u4e2a\u76f8\u5f53\u4e8c\u5143\u7684\u7ed3\u679c\uff0c\u8868\u660eNanaBis&#x2122;\u4f5c\u4e3a\u4e00\u79cd\u72ec\u7acb\u7684\u836f\u7269\u5236\u5242\uff0c\u53ef\u4ee5\u63d0\u4f9b\u6bd4\u5bf9\u7167\u836f\u7f9f\u8003\u916e\u66f4\u597d\u7684\u7f13\u89e3\u3002\u201d<\/p>\n<p>Hall\u535a\u58eb\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u7684\u76ee\u6807\u662f\u7b2c\u4e00\u4e2a\u5b8c\u5168\u6ce8\u518c\u7684CBD\/THC\u4ea7\u54c1\uff0c\u5b83\u5df2\u7ecf\u4e0e\u4e00\u79cd\u963f\u7247\u7c7b\u836f\u7269\u6b63\u9762\u5bf9\u6297\uff0c\u800c\u4e14\u88ab\u8bc1\u660e\u662f\u66f4\u597d\u7684\u2014\u2014\u5728\u6211\u4eec\u63a8\u8fdb\u8fd9\u4e2a\u9879\u76ee\u65f6\uff0c\u6211\u4eec\u5c06\u6f84\u6e05\u2018\u66f4\u597d\u2019\u7684[\u542b\u4e49]\u3002\u201d<\/p>\n<h2>\u764c\u75c7\u9aa8\u75db\u548c\u76ee\u524d\u7684\u6cbb\u7597<\/h2>\n<p>\u764c\u6027\u9aa8\u75db\u662f\u533b\u5b66\u4e0a\u5b9a\u4e49\u7684\u795e\u7ecf\u6027\u75bc\u75db\uff0c\u5177\u6709\u9000\u884c\u6027\u3002<\/p>\n<p>\u6839\u636eMedlab\u7684\u6570\u636e\uff0c\u5728\u7f8e\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u52a0\u62ff\u5927\uff0c\u6bcf\u5e74\u7ea6\u670970\u4e07\u540d\u65b0\u60a3\u8005\u53d7\u5230\u8fd9\u79cd\u7279\u6b8a\u75bc\u75db\u6cbb\u7597\u7684\u5f71\u54cd\uff0c\u5168\u7403\u5e02\u573a\u7ea6\u4e3a12.2\u4ebf\u7f8e\u5143(15.8\u4ebf\u6fb3\u5143)\uff0c\u4e14\u4ecd\u5728\u589e\u957f\u3002<\/p>\n<p>Hall\u535a\u58eb\u5c06\u8fd9\u79cd\u75bc\u75db\u63cf\u8ff0\u4e3a\u4e00\u79cd\u201c\u9669\u6076\u201d\u7684\u75bc\u75db\uff0c\u5b83\u4f1a\u8ba9\u75c5\u4eba\u6709\u597d\u65e5\u5b50\u4e5f\u6709\u574f\u65e5\u5b50\uff0c\u4f46\u901a\u5e38\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\u4f1a\u53d8\u5f97\u66f4\u7cdf\u3002<\/p>\n<p>\u201c\u5f3a\u5316\u6cbb\u7597\u9886\u57df\u7684\u533b\u7597\u521b\u65b0\u6bcf\u5e74\u90fd\u6709\u51fa\u8272\u8868\u73b0\u3002\u4f46\u662f\uff0c\u5c3d\u7ba1\u60a3\u8005\u7684\u5b58\u6d3b\u7387\u63d0\u9ad8\u4e86\uff0c\u4f46\u5728\u6cbb\u7597\u75bc\u75db\u7684\u7b49\u5f0f\u7684\u53e6\u4e00\u8fb9\uff0c\u8fd8\u6ca1\u6709\u63d0\u4f9b\u521b\u65b0\u3002\u201d<\/p>\n<p>\u4ed6\u8bf4:\u201c\u8d8a\u6765\u8d8a\u591a\u7684\u60a3\u8005\u80fd\u591f\u62b5\u6297\u764c\u75c7\uff0c\u4f46\u4ed6\u4eec\u5728\u75bc\u75db\u4e2d\u6d3b\u5f97\u66f4\u957f\uff0c\u8fd9\u5c31\u53d8\u6210\u4e86\u6ed1\u5761\u6548\u5e94\u3002\u201d<\/p>\n<p>\u4e16\u754c\u536b\u751f\u7ec4\u7ec7(WHO)\u91c7\u7528\u4e86\u4e00\u79cd\u4e09\u6b65\u8d70\u6a21\u5f0f\uff0c\u6307\u5bfc\u533b\u751f\u5982\u4f55\u51cf\u8f7b\u75bc\u75db\uff0c\u4ee5\u51cf\u5c11\u5f3a\u6548\u963f\u7247\u7c7b\u836f\u7269\u7684\u4f7f\u7528\u3002<\/p>\n<p>\u7b2c\u4e00\u6b65\u8981\u6c42\u4f7f\u7528\u975e\u963f\u7247\u7c7b\u9547\u75db\u836f\uff0c\u5982\u975e\u753e\u4f53\u6297\u708e\u836f\uff0c\u7136\u540e\u6539\u7528\u5f31\u963f\u7247\u7c7b\u6216\u8054\u5408\u963f\u7247\u7c7b\u836f\u7269\uff0c\u5982\u53ef\u5f85\u56e0\u548c\u66f2\u9a6c\u591a\uff0c\u7528\u4e8e\u4e2d\u5ea6\u75bc\u75db\u6cbb\u7597\uff0c\u6700\u540e\u4e00\u6b65\u662f\u4f7f\u7528\u5f3a\u963f\u7247\u7c7b\u836f\u7269\uff0c\u5982\u5417\u5561\u6216\u7f9f\u8003\u916e\uff0c\u7528\u4e8e\u91cd\u5ea6\u75bc\u75db\u6cbb\u7597\u3002<\/p>\n<p>Hall\u535a\u58eb\u8bf4:\u201c\u95ee\u9898\u662f[\u60a3\u764c\u9aa8\u75db\u7684]\u60a3\u8005\u5c06\u4f1a\u76f8\u5bf9\u8f83\u5feb\u5730\u8f6c\u5411\u963f\u7247\u7c7b\u836f\u7269\u3002\u201d<\/p>\n<p>\u4ed6\u6307\u51fa\uff0c\u533b\u5b66\u6587\u732e\u663e\u793a\uff0c\u5927\u7ea675%\u7684\u764c\u75c7\u6027\u9aa8\u75db\u60a3\u8005\u8ba4\u4e3a\u4ed6\u4eec\u7684\u75bc\u75db\u6ca1\u6709\u5f97\u5230\u5145\u5206\u7684\u63a7\u5236\u3002<\/p>\n<p>\u201c\u8fd9\u4e00\u70b9\u975e\u5e38\u91cd\u8981\uff0c\u6709\u4e24\u4e2a\u539f\u56e0:\u7b2c\u4e00\uff0c\u8fd9\u79cd\u75bc\u75db\u6ca1\u6709\u6cbb\u6108\u65b9\u6cd5\uff0c\u53ea\u6709\u7ba1\u7406\u65b9\u6cd5;\u5176\u6b21\uff0c75%\u5bf9\u4e8e\u4e00\u4e2a\u6211\u4eec\u7aed\u5c3d\u5168\u529b\u60f3\u8981\u5ef6\u957f\u751f\u547d\u7684\u7fa4\u4f53\u6765\u8bf4\u662f\u4e2a\u53ef\u6015\u7684\u6570\u5b57\u3002\u201d<\/p>\n<h2>\u521b\u65b0\u4ea4\u4ed8\u7cfb\u7edf<\/h2>\n<p>Medlab\u5019\u9009\u836f\u7269NanaBis&#x2122;\u7684\u4e00\u4e2a\u5173\u952e\u533a\u522b\u662f\u5b83\u7684\u4f20\u9012\u7cfb\u7edf\uff0c\u8be5\u516c\u53f8\u7684\u4e13\u5229\u7eb3\u7c73\u7c92\u5b50\u836f\u7269\u5e73\u53f0\u88ab\u79f0\u4e3aNanoCelle&#x2122;\u3002<\/p>\n<p>\u8be5\u6280\u672f\u63d0\u4f9b\u7eb3\u7c73\u9897\u7c92\u5927\u5c0f\u7684\u6d3b\u6027\u836f\u7269\u6210\u5206(API)\u5206\u5b50\uff0c\u901a\u8fc7\u53e3\u8154\u988a\u7c98\u819c(\u8138\u988a\u5185\u90e8\u7684\u7c89\u7ea2\u8272\u8089\u8d28)\u5438\u6536\u3002\u4ee5NanaBis&#x2122;\u4e3a\u4f8b\uff0c\u8fd9\u662f2.5\u6beb\u514b\u7684CBD\u548cTHC\u4ee5\u7ec6\u55b7\u96fe\u7684\u5f62\u5f0f\u63d0\u4f9b\u3002<\/p>\n<p>Hall\u535a\u58eb\u89e3\u91ca\u8bf4:\u201c\u8fd9\u5c31\u662f\u4e3a\u4ec0\u4e48\u6211\u4eec\u53ef\u4ee5\u8d1f\u62c5\u5f97\u8d77\u975e\u5e38\u5c0f\u7684\u5242\u91cf\u2014\u2014\u6211\u4eec\u7684\u836f\u7269\u5f88\u5feb\u8fdb\u5165\u8840\u6db2\uff0c\u800c\u75c5\u4eba\u5374\u4e0d\u6444\u5165\u3002\u201d<\/p>\n<p>\u201c\u4f8b\u5982\uff0c\u5982\u679c\u75c5\u4eba\u541e\u4e0b\u4e00\u7247\u836f\u7247\uff0c\u5373\u4f7f\u80a0\u9053\u548c\u809d\u529f\u80fd\u6b63\u5e38\uff0c\u4ed6\u4eec\u6700\u591a\u4e5f\u4f1a\u5438\u653610%\u5de6\u53f3\u3002\u8fd9\u662f\u5728\u4f60\u8ba1\u7b97\u51fa\u6709\u591a\u5c11API\u5b58\u5728\u4e8e\u5e73\u677f\u7535\u8111\u4e4b\u524d\u3002\u201d<\/p>\n<p>\u56e0\u6b64\uff0c\u8fd9\u79cd\u7ed9\u836f\u65b9\u6cd5\u4e0d\u4ec5\u53ef\u4ee5\u7ed5\u8fc7\u809d\u810f\u3001\u80be\u810f\u6216\u80c3\u80a0\u9053\u4e0d\u9002\uff0c\u8fd9\u4e9b\u53ef\u80fd\u662f\u6444\u5165\u7684\u526f\u4f5c\u7528\uff0c\u8fd9\u610f\u5473\u7740\u9700\u8981\u66f4\u4f4e\u5242\u91cf\u7684API\u3002<\/p>\n<p>\u201c\u8be5\u7ed9\u836f\u5e73\u53f0\u53ef\u4ee5\u663e\u8457\u6539\u53d8\u60a3\u8005\u7684\u5b89\u5168\u72b6\u51b5\u2026\u2026\u4e0e\u963f\u7247\u7c7b\u836f\u7269\u670d\u7528\u8005\u76f8\u6bd4\uff0c\u4f7f\u7528NanaBis&#x2122;\u7684\u60a3\u8005\u5728\u4efb\u4f55\u65f6\u5019\u8840\u6db2\u4e2d\u5faa\u73af\u7684\u5417\u5561\u5f53\u91cf\u663e\u8457\u51cf\u5c11\u3002\u201d\u8fd9\u4e0e\u6211\u4eec\u4ea4\u8c08\u8fc7\u7684\u76d1\u7ba1\u673a\u6784\u4ea7\u751f\u4e86\u5171\u9e23\uff0c\u201dHall\u535a\u58eb\u8bf4\u3002<\/p>\n<p>\u201cNanoCelle&#x2122;\u662f\u72ec\u4e00\u65e0\u4e8c\u7684\u2026\u2026\u6211\u4eec\u5df2\u7ecf\u67e5\u9605\u4e86\u6570\u767e\u4e2a\u5916\u89c2\u3001\u611f\u89c9\u3001\u58f0\u97f3\u6216\u6c14\u5473\u7c7b\u4f3c\u4e1c\u897f\u7684\u4e13\u5229\u6587\u732e\u3002\u6211\u77e5\u9053\u5728\u6fb3\u5927\u5229\u4e9a\u7684\u60c5\u51b5\u4e0b\uff0c\u4ed6\u4eec\u6ca1\u6709\u4e00\u4e2a\u63a5\u8fd1\u3002\u201d<\/p>\n<h2>\u8bd5\u9a8c\u65f6\u95f4<\/h2>\n<p>Hall\u535a\u58eb\u8bf4\uff0c\u9884\u8ba1\u5c06\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5f00\u59cb\u7684\u7b2c\u4e09\u9636\u6bb5\u8bd5\u9a8c\u5c06\u6bd4\u4e4b\u524d\u7684\u5de5\u4f5c\u66f4\u77ed\u3001\u66f4\u4e0d\u201c\u8d39\u529b\u201d\uff0c\u60a3\u8005\u9884\u8ba1\u5c06\u5728\u5927\u7ea6\u201c17\u5468\u201d\u5185\u5b8c\u6210\u7814\u7a76\u3002<\/p>\n<p>\u201c\u5728\u8bb8\u591a\u60c5\u51b5\u4e0b\uff0c\u6211\u4eec\u65e9\u671f\u7684\u5de5\u4f5c\u8981\u4e48\u662f\u901a\u8fc7\u6211\u4eec\uff0c\u8981\u4e48\u662f\u901a\u8fc7\u652f\u6301(\u6fb3\u5927\u5229\u4e9a)\u548c\u6d77\u5916\u7684\u5404\u4e2a\u90e8\u95e8\u6765\u63d0\u901f\u3002\u8fd9\u53d1\u51fa\u4e86\u975e\u5e38\u5f3a\u70c8\u7684\u4fe1\u53f7\uff0c\u4f5c\u4e3a\u4e00\u4e2a\u8463\u4e8b\u4f1a\u3001\u4e00\u4e2a\u7ba1\u7406\u56e2\u961f\u3001\u4e00\u7fa4\u533b\u751f\u6216\u7814\u7a76\u4eba\u5458\uff0c\u8fd9\u8ba9\u6211\u4eec\u975e\u5e38\u5174\u594b\u3002\u201d<\/p>\n<p>\u8ba1\u5212\u5728\u5168\u7403\u62db\u52df\u7ea6360\u540d\u60a3\u8005\uff0c\u5176\u4e2d\u7ea6\u4e09\u5206\u4e4b\u4e00\u6765\u81ea\u6fb3\u5927\u5229\u4e9a\u3001\u82f1\u56fd\u548c\u7f8e\u56fd\u3002<\/p>\n<p>Hall\u535a\u58eb\u8bf4:\u201c\u5982\u679c\u4e00\u5207\u987a\u5229\uff0c\u6211\u4eec\u9884\u8ba1\u5c06\u5728\u5317\u534a\u7403\u590f\u5b63\u5bf9\u60a3\u8005\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002\u201d<\/p>\n<p>\u4ed6\u8bf4\uff0c\u63a5\u4e0b\u6765\u7684\u6b65\u9aa4\u5305\u62ec\u5171\u540c\u7b7e\u7f72\u533b\u9662\u7684\u5404\u79cd\u573a\u5730\u534f\u8bae\uff0c\u5e76\u786e\u4fdd\u516c\u53f8\u83b7\u5f97\u6240\u6709\u7684\u6279\u51c6\u3002<\/p>\n<p>\u201c\u5c31\u7f8e\u56fd\u548c\u82f1\u56fd\u7684\u60c5\u51b5\u800c\u8a00\uff0c\u4e3a\u4e86\u8ba9\u4ea7\u54c1\u5408\u6cd5\u8fdb\u5165\u82f1\u56fd\uff0c\u6211\u4eec\u5fc5\u987b\u505a\u4e00\u4e9b\u540e\u52e4\u5de5\u4f5c\u3002\u7136\u540e\uff0c\u5728\u653f\u5e9c\u7684\u652f\u6301\u4e0b\uff0c\u6211\u4eec\u5c06\u5c3d\u5feb\u8fdb\u5165\u6bcf\u4f4d\u60a3\u8005\u7684\u9886\u5730\u3002\u201d<\/p>\n<p>Hall\u535a\u58eb\u8bf4\uff0c\u4ece\u6536\u5165\u7684\u89d2\u5ea6\u6765\u770b\uff0c\u8be5\u516c\u53f8\u7684\u76ee\u6807\u662f\u4e0e\u66f4\u6709\u7eaa\u5f8b\u7684\u8de8\u56fd\u5236\u836f\u516c\u53f8\u4e4b\u4e00\u8fbe\u6210\u4e00\u9879\u5927\u578b\u5408\u4f5c\u534f\u8bae\uff0c\u5e76\u5f00\u53d1\u51fa\u4e00\u79cd\u5c06\u6210\u4e3a\u4e00\u6d41\/\u539f\u521b\u6027\u54c1\u724c\u7684\u836f\u7269\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u5f53\u6211\u4eec\u5ba3\u5e03\u8fd9\u4e00\u8bc1\u636e\uff0c\u6211\u4eec\u5c31\u4f1a\u51cf\u5c11\u4e0e\u4e4b\u76f8\u5173\u7684\u84dd\u5929\uff0c\u73b0\u5728\u662f\u5f00\u59cb\u5408\u4f5c\u7684\u6b63\u786e\u65f6\u673a\u5c31\u53d8\u5f97\u8d8a\u6765\u8d8a\u53ef\u884c\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002 \u8be5\u516c\u53f8\u7684\u76ee\u6807\u662f\u4e3a\u5df2\u786e\u8bca\u7684\u6162\u6027\u75be\u75c5(\u5305\u62ec\u75bc\u75db\u3001\u6291\u90c1\u75c7)\u5f00\u53d1\u6cbb\u7597\u9014\u5f84\u3002\u5176\u6700\u5148\u8fdb\u7684\u5019\u9009\u836f\u7269NanaBis&#x2122;\u662f\u4e00\u79cd\u57fa\u4e8e\u5927\u9ebb\u7d20\u7684\u836f\u7269\uff0c\u65e8\u5728\u6cbb\u7597\u764c\u75c7\u5f15\u8d77\u7684\u9aa8\u75db\u3002 \u8be5\u836f\u7269\u5df2\u88ab\u6279\u51c6\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u82f1\u56fd\u8fdb\u884c\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0a\u5468Medlab\u5ba3\u5e03\u4e86\u8fd9\u4e00\u6d88\u606f Medlab\u8463\u4e8b\u603b\u7ecf\u7406Sean Hall\u535a\u58eb\u5728\u63a5\u53d7Small Caps\u91c7\u8bbf\u65f6\u8868\u793a\uff0c\u4ed6\u76f8\u4fe1\u516c\u53f8\u80fd\u591f\u8bc1\u660eNanaBis&#x2122;\u662f\u4e00\u79cd\u73b0\u5b9e\u4e16\u754c\u4e2d\u53ef\u884c\u7684\u9547\u75db\u7c7b\u963f\u7247\u7c7b\u836f\u7269\u66ff\u4ee3\u54c1\u3002 \u4ed6\u8bf4\uff0cMedlab\u7684\u76ee\u6807\u662f\u901a\u8fc7\u4e09\u671f\u8bd5\u9a8c\uff0c\u201c\u826f\u597d\u7684\u5408\u4f5c\u4f19\u4f34\u548c\u975e\u5e38\u540c\u8d28\u578b\u7684\u60a3\u8005\u7ec4\uff0c\u5f97\u51fa\u4e00\u4e2a\u76f8\u5f53\u4e8c\u5143\u7684\u7ed3\u679c\uff0c\u8868\u660eNanaBis&#x2122;\u4f5c\u4e3a\u4e00\u79cd\u72ec\u7acb\u7684\u836f\u7269\u5236\u5242\uff0c\u53ef\u4ee5\u63d0\u4f9b\u6bd4\u5bf9\u7167\u836f\u7f9f\u8003\u916e\u66f4\u597d\u7684\u7f13\u89e3\u3002\u201d Hall\u535a\u58eb\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u7684\u76ee\u6807\u662f\u7b2c\u4e00\u4e2a\u5b8c\u5168\u6ce8\u518c\u7684CBD\/THC\u4ea7\u54c1\uff0c\u5b83\u5df2\u7ecf\u4e0e\u4e00\u79cd\u963f\u7247\u7c7b\u836f\u7269\u6b63\u9762\u5bf9\u6297\uff0c\u800c\u4e14\u88ab\u8bc1\u660e\u662f\u66f4\u597d\u7684\u2014\u2014\u5728\u6211\u4eec\u63a8\u8fdb\u8fd9\u4e2a\u9879\u76ee\u65f6\uff0c\u6211\u4eec\u5c06\u6f84\u6e05\u2018\u66f4\u597d\u2019\u7684[\u542b\u4e49]\u3002\u201d \u764c\u75c7\u9aa8\u75db\u548c\u76ee\u524d\u7684\u6cbb\u7597 \u764c\u6027\u9aa8\u75db\u662f\u533b\u5b66\u4e0a\u5b9a\u4e49\u7684\u795e\u7ecf\u6027\u75bc\u75db\uff0c\u5177\u6709\u9000\u884c\u6027\u3002 \u6839\u636eMedlab\u7684\u6570\u636e\uff0c\u5728\u7f8e\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u52a0\u62ff\u5927\uff0c\u6bcf\u5e74\u7ea6\u670970\u4e07\u540d\u65b0\u60a3\u8005\u53d7\u5230\u8fd9\u79cd\u7279\u6b8a\u75bc\u75db\u6cbb\u7597\u7684\u5f71\u54cd\uff0c\u5168\u7403\u5e02\u573a\u7ea6\u4e3a12.2\u4ebf\u7f8e\u5143(15.8\u4ebf\u6fb3\u5143)\uff0c\u4e14\u4ecd\u5728\u589e\u957f\u3002 Hall\u535a\u58eb\u5c06\u8fd9\u79cd\u75bc\u75db\u63cf\u8ff0\u4e3a\u4e00\u79cd\u201c\u9669\u6076\u201d\u7684\u75bc\u75db\uff0c\u5b83\u4f1a\u8ba9\u75c5\u4eba\u6709\u597d\u65e5\u5b50\u4e5f\u6709\u574f\u65e5\u5b50\uff0c\u4f46\u901a\u5e38\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\u4f1a\u53d8\u5f97\u66f4\u7cdf\u3002 \u201c\u5f3a\u5316\u6cbb\u7597\u9886\u57df\u7684\u533b\u7597\u521b\u65b0\u6bcf\u5e74\u90fd\u6709\u51fa\u8272\u8868\u73b0\u3002\u4f46\u662f\uff0c\u5c3d\u7ba1\u60a3\u8005\u7684\u5b58\u6d3b\u7387\u63d0\u9ad8\u4e86\uff0c\u4f46\u5728\u6cbb\u7597\u75bc\u75db\u7684\u7b49\u5f0f\u7684\u53e6\u4e00\u8fb9\uff0c\u8fd8\u6ca1\u6709\u63d0\u4f9b\u521b\u65b0\u3002\u201d \u4ed6\u8bf4:\u201c\u8d8a\u6765\u8d8a\u591a\u7684\u60a3\u8005\u80fd\u591f\u62b5\u6297\u764c\u75c7\uff0c\u4f46\u4ed6\u4eec\u5728\u75bc\u75db\u4e2d\u6d3b\u5f97\u66f4\u957f\uff0c\u8fd9\u5c31\u53d8\u6210\u4e86\u6ed1\u5761\u6548\u5e94\u3002\u201d \u4e16\u754c\u536b\u751f\u7ec4\u7ec7(WHO)\u91c7\u7528\u4e86\u4e00\u79cd\u4e09\u6b65\u8d70\u6a21\u5f0f\uff0c\u6307\u5bfc\u533b\u751f\u5982\u4f55\u51cf\u8f7b\u75bc\u75db\uff0c\u4ee5\u51cf\u5c11\u5f3a\u6548\u963f\u7247\u7c7b\u836f\u7269\u7684\u4f7f\u7528\u3002 \u7b2c\u4e00\u6b65\u8981\u6c42\u4f7f\u7528\u975e\u963f\u7247\u7c7b\u9547\u75db\u836f\uff0c\u5982\u975e\u753e\u4f53\u6297\u708e\u836f\uff0c\u7136\u540e\u6539\u7528\u5f31\u963f\u7247\u7c7b\u6216\u8054\u5408\u963f\u7247\u7c7b\u836f\u7269\uff0c\u5982\u53ef\u5f85\u56e0\u548c\u66f2\u9a6c\u591a\uff0c\u7528\u4e8e\u4e2d\u5ea6\u75bc\u75db\u6cbb\u7597\uff0c\u6700\u540e\u4e00\u6b65\u662f\u4f7f\u7528\u5f3a\u963f\u7247\u7c7b\u836f\u7269\uff0c\u5982\u5417\u5561\u6216\u7f9f\u8003\u916e\uff0c\u7528\u4e8e\u91cd\u5ea6\u75bc\u75db\u6cbb\u7597\u3002 Hall\u535a\u58eb\u8bf4:\u201c\u95ee\u9898\u662f[\u60a3\u764c\u9aa8\u75db\u7684]\u60a3\u8005\u5c06\u4f1a\u76f8\u5bf9\u8f83\u5feb\u5730\u8f6c\u5411\u963f\u7247\u7c7b\u836f\u7269\u3002\u201d \u4ed6\u6307\u51fa\uff0c\u533b\u5b66\u6587\u732e\u663e\u793a\uff0c\u5927\u7ea675%\u7684\u764c\u75c7\u6027\u9aa8\u75db\u60a3\u8005\u8ba4\u4e3a\u4ed6\u4eec\u7684\u75bc\u75db\u6ca1\u6709\u5f97\u5230\u5145\u5206\u7684\u63a7\u5236\u3002 \u201c\u8fd9\u4e00\u70b9\u975e\u5e38\u91cd\u8981\uff0c\u6709\u4e24\u4e2a\u539f\u56e0:\u7b2c\u4e00\uff0c\u8fd9\u79cd\u75bc\u75db\u6ca1\u6709\u6cbb\u6108\u65b9\u6cd5\uff0c\u53ea\u6709\u7ba1\u7406\u65b9\u6cd5;\u5176\u6b21\uff0c75%\u5bf9\u4e8e\u4e00\u4e2a\u6211\u4eec\u7aed\u5c3d\u5168\u529b\u60f3\u8981\u5ef6\u957f\u751f\u547d\u7684\u7fa4\u4f53\u6765\u8bf4\u662f\u4e2a\u53ef\u6015\u7684\u6570\u5b57\u3002\u201d \u521b\u65b0\u4ea4\u4ed8\u7cfb\u7edf Medlab\u5019\u9009\u836f\u7269NanaBis&#x2122;\u7684\u4e00\u4e2a\u5173\u952e\u533a\u522b\u662f\u5b83\u7684\u4f20\u9012\u7cfb\u7edf\uff0c\u8be5\u516c\u53f8\u7684\u4e13\u5229\u7eb3\u7c73\u7c92\u5b50\u836f\u7269\u5e73\u53f0\u88ab\u79f0\u4e3aNanoCelle&#x2122;\u3002 \u8be5\u6280\u672f\u63d0\u4f9b\u7eb3\u7c73\u9897\u7c92\u5927\u5c0f\u7684\u6d3b\u6027\u836f\u7269\u6210\u5206(API)\u5206\u5b50\uff0c\u901a\u8fc7\u53e3\u8154\u988a\u7c98\u819c(\u8138\u988a\u5185\u90e8\u7684\u7c89\u7ea2\u8272\u8089\u8d28)\u5438\u6536\u3002\u4ee5NanaBis&#x2122;\u4e3a\u4f8b\uff0c\u8fd9\u662f2.5\u6beb\u514b\u7684CBD\u548cTHC\u4ee5\u7ec6\u55b7\u96fe\u7684\u5f62\u5f0f\u63d0\u4f9b\u3002 Hall\u535a\u58eb\u89e3\u91ca\u8bf4:\u201c\u8fd9\u5c31\u662f\u4e3a\u4ec0\u4e48\u6211\u4eec\u53ef\u4ee5\u8d1f\u62c5\u5f97\u8d77\u975e\u5e38\u5c0f\u7684\u5242\u91cf\u2014\u2014\u6211\u4eec\u7684\u836f\u7269\u5f88\u5feb\u8fdb\u5165\u8840\u6db2\uff0c\u800c\u75c5\u4eba\u5374\u4e0d\u6444\u5165\u3002\u201d \u201c\u4f8b\u5982\uff0c\u5982\u679c\u75c5\u4eba\u541e\u4e0b\u4e00\u7247\u836f\u7247\uff0c\u5373\u4f7f\u80a0\u9053\u548c\u809d\u529f\u80fd\u6b63\u5e38\uff0c\u4ed6\u4eec\u6700\u591a\u4e5f\u4f1a\u5438\u653610%\u5de6\u53f3\u3002\u8fd9\u662f\u5728\u4f60\u8ba1\u7b97\u51fa\u6709\u591a\u5c11API\u5b58\u5728\u4e8e\u5e73\u677f\u7535\u8111\u4e4b\u524d\u3002\u201d \u56e0\u6b64\uff0c\u8fd9\u79cd\u7ed9\u836f\u65b9\u6cd5\u4e0d\u4ec5\u53ef\u4ee5\u7ed5\u8fc7\u809d\u810f\u3001\u80be\u810f\u6216\u80c3\u80a0\u9053\u4e0d\u9002\uff0c\u8fd9\u4e9b\u53ef\u80fd\u662f\u6444\u5165\u7684\u526f\u4f5c\u7528\uff0c\u8fd9\u610f\u5473\u7740\u9700\u8981\u66f4\u4f4e\u5242\u91cf\u7684API\u3002 \u201c\u8be5\u7ed9\u836f\u5e73\u53f0\u53ef\u4ee5\u663e\u8457\u6539\u53d8\u60a3\u8005\u7684\u5b89\u5168\u72b6\u51b5\u2026\u2026\u4e0e\u963f\u7247\u7c7b\u836f\u7269\u670d\u7528\u8005\u76f8\u6bd4\uff0c\u4f7f\u7528NanaBis&#x2122;\u7684\u60a3\u8005\u5728\u4efb\u4f55\u65f6\u5019\u8840\u6db2\u4e2d\u5faa\u73af\u7684\u5417\u5561\u5f53\u91cf\u663e\u8457\u51cf\u5c11\u3002\u201d\u8fd9\u4e0e\u6211\u4eec\u4ea4\u8c08\u8fc7\u7684\u76d1\u7ba1\u673a\u6784\u4ea7\u751f\u4e86\u5171\u9e23\uff0c\u201dHall\u535a\u58eb\u8bf4\u3002 \u201cNanoCelle&#x2122;\u662f\u72ec\u4e00\u65e0\u4e8c\u7684\u2026\u2026\u6211\u4eec\u5df2\u7ecf\u67e5\u9605\u4e86\u6570\u767e\u4e2a\u5916\u89c2\u3001\u611f\u89c9\u3001\u58f0\u97f3\u6216\u6c14\u5473\u7c7b\u4f3c\u4e1c\u897f\u7684\u4e13\u5229\u6587\u732e\u3002\u6211\u77e5\u9053\u5728\u6fb3\u5927\u5229\u4e9a\u7684\u60c5\u51b5\u4e0b\uff0c\u4ed6\u4eec\u6ca1\u6709\u4e00\u4e2a\u63a5\u8fd1\u3002\u201d \u8bd5\u9a8c\u65f6\u95f4 Hall\u535a\u58eb\u8bf4\uff0c\u9884\u8ba1\u5c06\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5f00\u59cb\u7684\u7b2c\u4e09\u9636\u6bb5\u8bd5\u9a8c\u5c06\u6bd4\u4e4b\u524d\u7684\u5de5\u4f5c\u66f4\u77ed\u3001\u66f4\u4e0d\u201c\u8d39\u529b\u201d\uff0c\u60a3\u8005\u9884\u8ba1\u5c06\u5728\u5927\u7ea6\u201c17\u5468\u201d\u5185\u5b8c\u6210\u7814\u7a76\u3002 \u201c\u5728\u8bb8\u591a\u60c5\u51b5\u4e0b\uff0c\u6211\u4eec\u65e9\u671f\u7684\u5de5\u4f5c\u8981\u4e48\u662f\u901a\u8fc7\u6211\u4eec\uff0c\u8981\u4e48\u662f\u901a\u8fc7\u652f\u6301(\u6fb3\u5927\u5229\u4e9a)\u548c\u6d77\u5916\u7684\u5404\u4e2a\u90e8\u95e8\u6765\u63d0\u901f\u3002\u8fd9\u53d1\u51fa\u4e86\u975e\u5e38\u5f3a\u70c8\u7684\u4fe1\u53f7\uff0c\u4f5c\u4e3a\u4e00\u4e2a\u8463\u4e8b\u4f1a\u3001\u4e00\u4e2a\u7ba1\u7406\u56e2\u961f\u3001\u4e00\u7fa4\u533b\u751f\u6216\u7814\u7a76\u4eba\u5458\uff0c\u8fd9\u8ba9\u6211\u4eec\u975e\u5e38\u5174\u594b\u3002\u201d \u8ba1\u5212\u5728\u5168\u7403\u62db\u52df\u7ea6360\u540d\u60a3\u8005\uff0c\u5176\u4e2d\u7ea6\u4e09\u5206\u4e4b\u4e00\u6765\u81ea\u6fb3\u5927\u5229\u4e9a\u3001\u82f1\u56fd\u548c\u7f8e\u56fd\u3002 Hall\u535a\u58eb\u8bf4:\u201c\u5982\u679c\u4e00\u5207\u987a\u5229\uff0c\u6211\u4eec\u9884\u8ba1\u5c06\u5728\u5317\u534a\u7403\u590f\u5b63\u5bf9\u60a3\u8005\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002\u201d \u4ed6\u8bf4\uff0c\u63a5\u4e0b\u6765\u7684\u6b65\u9aa4\u5305\u62ec\u5171\u540c\u7b7e\u7f72\u533b\u9662\u7684\u5404\u79cd\u573a\u5730\u534f\u8bae\uff0c\u5e76\u786e\u4fdd\u516c\u53f8\u83b7\u5f97\u6240\u6709\u7684\u6279\u51c6\u3002 \u201c\u5c31\u7f8e\u56fd\u548c\u82f1\u56fd\u7684\u60c5\u51b5\u800c\u8a00\uff0c\u4e3a\u4e86\u8ba9\u4ea7\u54c1\u5408\u6cd5\u8fdb\u5165\u82f1\u56fd\uff0c\u6211\u4eec\u5fc5\u987b\u505a\u4e00\u4e9b\u540e\u52e4\u5de5\u4f5c\u3002\u7136\u540e\uff0c\u5728\u653f\u5e9c\u7684\u652f\u6301\u4e0b\uff0c\u6211\u4eec\u5c06\u5c3d\u5feb\u8fdb\u5165\u6bcf\u4f4d\u60a3\u8005\u7684\u9886\u5730\u3002\u201d Hall\u535a\u58eb\u8bf4\uff0c\u4ece\u6536\u5165\u7684\u89d2\u5ea6\u6765\u770b\uff0c\u8be5\u516c\u53f8\u7684\u76ee\u6807\u662f\u4e0e\u66f4\u6709\u7eaa\u5f8b\u7684\u8de8\u56fd\u5236\u836f\u516c\u53f8\u4e4b\u4e00\u8fbe\u6210\u4e00\u9879\u5927\u578b\u5408\u4f5c\u534f\u8bae\uff0c\u5e76\u5f00\u53d1\u51fa\u4e00\u79cd\u5c06\u6210\u4e3a\u4e00\u6d41\/\u539f\u521b\u6027\u54c1\u724c\u7684\u836f\u7269\u3002 \u4ed6\u8bf4:\u201c\u5f53\u6211\u4eec\u5ba3\u5e03\u8fd9\u4e00\u8bc1\u636e\uff0c\u6211\u4eec\u5c31\u4f1a\u51cf\u5c11\u4e0e\u4e4b\u76f8\u5173\u7684\u84dd\u5929\uff0c\u73b0\u5728\u662f\u5f00\u59cb\u5408\u4f5c\u7684\u6b63\u786e\u65f6\u673a\u5c31\u53d8\u5f97\u8d8a\u6765\u8d8a\u53ef\u884c\u3002\u201d<\/p>\n","protected":false},"author":5,"featured_media":10597,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[610],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b<\/title>\n<meta name=\"description\" content=\"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b\" \/>\n<meta property=\"og:description\" content=\"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-26T22:36:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Medlab-Clinical-ASX-MDC-NanaBis-non-opioid-pain-treatment-phase-three-cancer-NanoCelle.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b\" \/>\n<meta name=\"twitter:description\" content=\"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Medlab-Clinical-ASX-MDC-NanaBis-non-opioid-pain-treatment-phase-three-cancer-NanoCelle.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/\",\"name\":\"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-01-26T22:36:23+00:00\",\"dateModified\":\"2023-08-29T18:01:53+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b","description":"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b","og_description":"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/","og_site_name":"smallcapsCN","article_published_time":"2021-01-26T22:36:23+00:00","article_modified_time":"2023-08-29T18:01:53+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Medlab-Clinical-ASX-MDC-NanaBis-non-opioid-pain-treatment-phase-three-cancer-NanoCelle.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b","twitter_description":"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/Medlab-Clinical-ASX-MDC-NanaBis-non-opioid-pain-treatment-phase-three-cancer-NanoCelle.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/","url":"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/","name":"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-01-26T22:36:23+00:00","dateModified":"2023-08-29T18:01:53+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u5982\u679c\u5373\u5c06\u8fdb\u884c\u7684\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53d6\u5f97\u6210\u529f\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u516c\u53f8Medlab Clinical (ASX: MDC)\u53ef\u80fd\u6210\u4e3a\u4e16\u754c\u4e0a\u7b2c\u4e00\u4e2a\u6ce8\u518c\u4ee5\u5927\u9ebb\u4e3a\u57fa\u7840\u7684\u836f\u7269\uff0c\u5728\u764c\u75c7\u76f8\u5173\u75bc\u75db\u6cbb\u7597\u65b9\u9762\u8868\u73b0\u4f18\u4e8e\u963f\u7247\u7c7b\u836f\u7269\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/medlab-clinical-nanabis-non-opioid-pain-treatment-phase-three-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Medlab Clinical\u8bc1\u5b9eNanaBis\u4f5c\u4e3a\u975e\u963f\u7247\u7c7b\u75bc\u75db\u6cbb\u7597\u836f\u7269\u7684\u6f5c\u529b"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2551"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2551"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2551\/revisions"}],"predecessor-version":[{"id":10596,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2551\/revisions\/10596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10597"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}